A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once daily
- 1 July 1995
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Infection
- Vol. 23 (4), 227-233
- https://doi.org/10.1007/bf01781203
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Quinolone Antimicrobial AgentsAnnual Review of Medicine, 1992
- Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumoniaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Fluoroquinolone Antimicrobial AgentsNew England Journal of Medicine, 1991
- Clinical Features and Management of Adverse Effects of Quinolone AntibacterialsDrug Safety, 1991
- Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non‐zero risk difference or non‐unity relative riskStatistics in Medicine, 1990
- Clinical Pharmacokinetics of CiprofloxacinClinical Pharmacokinetics, 1990
- Quinolone antimicrobial agents: Adverse effects and bacterial resistanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Oral Ciprofloxacin vs Parenteral Cefotaxime in the Treatment of Difficult Skin and Skin Structure InfectionsArchives of Internal Medicine, 1989
- Psychotoxic Effects of OfloxacinPharmacopsychiatry, 1989
- Use of ciprofloxacin in biliary sepsisInfection, 1988